Bio-Rad Laboratories (BIO) Liabilities and Shareholders Equity (2009 - 2026)
Bio-Rad Laboratories (BIO) reported Liabilities and Shareholders Equity of $9.8 billion for Q1 2026, up 3077.54% year-over-year from $308.1 million in Q1 2025, and down 7.44% on a QoQ basis from $10.6 billion in Q4 2025.
Bio-Rad Laboratories (BIO) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $9.8 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 3077.54% year-over-year to $9.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $40.3 billion (up 316.42% YoY) and the FY2025 annual result came in at $10.6 billion, up 12.95% from the prior year.
- Liabilities and Shareholders Equity eased to $9.8 billion in Q1 2026 per BIO's latest filing, from $10.6 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $14.4 billion in Q1 2022 and bottomed at $300000.0 in Q4 2023.
- The 5-year median for Liabilities and Shareholders Equity is $10.2 billion (2025), against an average of $8.5 billion.
- The widest annual swing landed in 2022, when Liabilities and Shareholders Equity tumbled 99.71%; it then soared 3121266.67% in 2024.
- Tracing BIO's Liabilities and Shareholders Equity over 5 years: stood at $600000.0 in 2022, then tumbled by 50.0% to $300000.0 in 2023, then soared by 3121266.67% to $9.4 billion in 2024, then rose by 12.95% to $10.6 billion in 2025, then slipped by 7.44% to $9.8 billion in 2026.
- Per Business Quant, the three latest BIO Liabilities and Shareholders Equity figures stand at $9.8 billion (Q1 2026), $10.6 billion (Q4 2025), and $9.7 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | 9.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.79 Bn |
| Dec 31, 2025 | 10.58 Bn |
| Sep 30, 2025 | 9.70 Bn |
| Jun 30, 2025 | 10.21 Bn |
| Mar 31, 2025 | 308.10 Mn |
| Dec 31, 2024 | 9.36 Bn |
| Mar 31, 2024 | 291.70 Mn |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 11.90 Bn |
| Jun 30, 2023 | 11.98 Bn |
| Mar 31, 2023 | 13.67 Bn |
| Dec 31, 2022 | 600,000.00 |
| Sep 30, 2022 | 12.06 Bn |
| Jun 30, 2022 | 12.68 Bn |
| Mar 31, 2022 | 14.37 Bn |
| Dec 31, 2021 | 207.70 Mn |
| Sep 30, 2021 | 19.95 Bn |
| Jun 30, 2021 | 15.12 Bn |
| Mar 31, 2021 | 13.93 Bn |
| Dec 31, 2020 | 401.20 Mn |
| Sep 30, 2020 | 12.02 Bn |
| Jun 30, 2020 | 10.10 Bn |
| Mar 31, 2020 | 8.68 Bn |
| Dec 31, 2019 | 8.01 Bn |
| Sep 30, 2019 | 7.18 Bn |
| Jun 30, 2019 | 7.65 Bn |
| Mar 31, 2019 | 6.86 Bn |
| Dec 31, 2018 | 5.61 Bn |
| Sep 30, 2018 | 6.72 Bn |
| Jun 30, 2018 | 6.39 Bn |
| Mar 31, 2018 | 6.21 Bn |
| Dec 31, 2017 | 4.27 Bn |
| Sep 30, 2017 | 4.19 Bn |
| Jun 30, 2017 | 4.14 Bn |
| Mar 31, 2017 | 3.95 Bn |
| Dec 31, 2016 | 3.85 Bn |
| Sep 30, 2016 | 4.02 Bn |
| Jun 30, 2016 | 3.87 Bn |
| Mar 31, 2016 | 3.75 Bn |
| Dec 31, 2015 | 3.71 Bn |
| Sep 30, 2015 | 3.67 Bn |
| Jun 30, 2015 | 3.53 Bn |
| Mar 31, 2015 | 3.33 Bn |
| Dec 31, 2014 | 3.34 Bn |
| Sep 30, 2014 | 3.39 Bn |
| Jun 30, 2014 | 3.47 Bn |
| Mar 31, 2014 | 3.44 Bn |
| Dec 31, 2013 | 3.39 Bn |
| Sep 30, 2013 | 3.28 Bn |
| Jun 30, 2013 | 3.48 Bn |
| Mar 31, 2013 | 3.46 Bn |
| Dec 31, 2012 | 3.44 Bn |
| Sep 30, 2012 | 3.30 Bn |
| Jun 30, 2012 | 3.17 Bn |
| Mar 31, 2012 | 3.19 Bn |
| Dec 31, 2011 | 3.10 Bn |
| Sep 30, 2011 | 2.97 Bn |
| Jun 30, 2011 | 3.04 Bn |
| Mar 31, 2011 | 2.91 Bn |
| Dec 31, 2010 | 3.06 Bn |
| Sep 30, 2010 | 2.68 Bn |
| Jun 30, 2010 | 2.53 Bn |
| Dec 31, 2009 | 2.54 Bn |